| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT07450859 A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal… |
Trial sites expanded: 3 -> 6 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07450859 | A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal… | Pancreatic Ductal Adenocarcinoma (PDAC) | Recruiting |
| NCT06840483 | Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer | Breast Cancer | Active, Not Recruiting |
| NCT06933329 | Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT06225596 | Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer… | Metastatic Urothelial Cancer | Active, Not Recruiting |
| NCT07681674 | Bicycle Continued Access Protocol (BiCAP) for Participants Receiving a Bicycle… | Advanced Solid Tumors | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT04561362 | Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | Urinary Bladder Neoplasm | Active, Not Recruiting |
| NCT04180371 | Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression | Advanced Solid Tumor Historically Known for High EphA2 Expression | Active, Not Recruiting |
| NCT05163041 | Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4… | Advanced Solid Tumor | Active, Not Recruiting |